Skeletal muscle alterations in Marfan syndrome: a systematic review

Al-Abcha A, Saleh Y, Mujer M et al (2020) Meta-analysis examining the usefulness of angiotensin receptor blockers for the prevention of aortic root dilation in patients with the Marfan syndrome. Am J Cardiol 128:101–106. https://doi.org/10.1016/j.amjcard.2020.04.034

Article  CAS  PubMed  Google Scholar 

Alameddine HS, Morgan JE (2016) Matrix metalloproteinases and tissue inhibitor of metalloproteinases in inflammation and fibrosis of skeletal muscles. J Neuromuscul Dis 3:455–473. https://doi.org/10.3233/JND-160183

Article  PubMed  PubMed Central  Google Scholar 

Arnold L, Henry A, Poron F et al (2007) Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 204:1057–1069. https://doi.org/10.1084/jem.20070075

Article  CAS  PubMed  PubMed Central  Google Scholar 

Asano K, Cantalupo A, Sedes L, Ramirez F (2022) The multiple functions of Fibrillin-1 microfibrils in organismal physiology. Int J Mol Sci 23:1892. https://doi.org/10.3390/ijms23031892

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beetz NL, Maier C, Shnayien S et al (2021) Artificial intelligence-based analysis of body composition in Marfan: skeletal muscle density and psoas muscle index predict aortic enlargement. J Cachexia Sarcopenia Muscle 12:993–999. https://doi.org/10.1002/jcsm.12731

Article  PubMed  PubMed Central  Google Scholar 

Benke K, Ágg B, Szilveszter B et al (2013) The role of transforming growth factor-beta in Marfan syndrome. Cardiol J 20:227–234. https://doi.org/10.5603/CJ.2013.0066

Article  PubMed  Google Scholar 

Benke K, Ágg B, Pólos M et al (2017) The effects of acute and elective cardiac surgery on the anxiety traits of patients with Marfan syndrome. BMC Psychiatry 17:253. https://doi.org/10.1186/s12888-017-1417-9

Article  PubMed  PubMed Central  Google Scholar 

Benninghoven D, Hamann D, von Kodolitsch Y et al (2017) Inpatient rehabilitation for adult patients with Marfan syndrome: an observational pilot study. Orphanet J Rare Dis 12:127. https://doi.org/10.1186/s13023-017-0679-0

Article  PubMed  PubMed Central  Google Scholar 

Bersini S, Gilardi M, Mora M et al (2018) Tackling muscle fibrosis: from molecular mechanisms to next generation engineered models to predict drug delivery. Adv Drug Deliv Rev 129:64–77. https://doi.org/10.1016/j.addr.2018.02.009

Article  CAS  PubMed  Google Scholar 

Biernacka A, Dobaczewski M, Frangogiannis NG (2011) TGF-β signaling in fibrosis. Growth Factors 29:196–202. https://doi.org/10.3109/08977194.2011.595714

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boileau C, Jondeau G, Mizuguchi T, Matsumoto N (2005) Molecular genetics of Marfan syndrome. Curr Opin Cardiol 20:194–200. https://doi.org/10.1097/01.hco.0000162398.21972.cd

Article  PubMed  Google Scholar 

Bowen TS, Schuler G, Adams V (2015) Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle 6:197–207. https://doi.org/10.1002/jcsm.12043

Article  PubMed  PubMed Central  Google Scholar 

Braga M, Bhasin S, Jasuja R et al (2012) Testosterone inhibits transforming growth factor-β signaling during myogenic differentiation and proliferation of mouse satellite cells: potential role of follistatin in mediating testosterone action. Mol Cell Endocrinol 350:39–52. https://doi.org/10.1016/j.mce.2011.11.019

Article  CAS  PubMed  Google Scholar 

Burchett ME, Ling I-F, Estus S (2011) FBN1 isoform expression varies in a tissue and development-specific fashion. Biochem Biophys Res Commun 411:323–328. https://doi.org/10.1016/j.bbrc.2011.06.140

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burks TN, Cohn RD (2011) Role of TGF-β signaling in inherited and acquired myopathies. Skelet Muscle 1:19. https://doi.org/10.1186/2044-5040-1-19

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cesari M, Pahor M, Lauretani F et al (2009) Skeletal muscle and mortality results from the InCHIANTI study. J Gerontol Biol Sci Med Sci 64:377–384. https://doi.org/10.1093/gerona/gln031

Article  Google Scholar 

Ciciliot S, Schiaffino S (2010) Regeneration of mammalian skeletal muscle. Basic mechanisms and clinical implications. Curr Pharm Des 16:906–914. https://doi.org/10.2174/138161210790883453

Article  CAS  PubMed  Google Scholar 

Cohn RD, van Erp C, Habashi JP et al (2007) Angiotensin II type 1 receptor Blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic States. Nat Med 13:204–210. https://doi.org/10.1038/nm1536

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cook JR, Carta L, Bénard L et al (2014) Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome. J Clin Invest 124:1329–1339. https://doi.org/10.1172/JCI71059

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crilley JG, Bendahan D, Boehm EA et al (2007) Investigation of muscle bioenergetics in the Marfan syndrome indicates reduced metabolic efficiency. J Cardiovasc Magn Reson 9:709–717. https://doi.org/10.1080/10976640701317028

Article  PubMed  Google Scholar 

De Bie S, De Paepe A, Delvaux I et al (2004) Marfan syndrome in Europe. Public Health Genomics 7:216–225. https://doi.org/10.1159/000082265

Article  Google Scholar 

de Koning L, Warnink-Kavelaars J, van Rossum M et al (2023) Physical activity and physical fitness in children with heritable connective tissue disorders. Front Pediatr 11:1057070. https://doi.org/10.3389/fped.2023.1057070

Article  PubMed  PubMed Central  Google Scholar 

de Koning L, Warnink-Kavelaars J, van Vulpen L et al (2025) Intensive physical training in children with heritable connective tissue disorders is feasible and safe: a pilot study. Disabil Rehabil 1–10. https://doi.org/10.1080/09638288.2025.2467772

De Paepe A, Devereux RB, Dietz HC et al (1996) Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62:417–426. https://doi.org/10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R

PubMed  Google Scholar 

de Souza RB, Kawahara EI, Farinha-Arcieri LE et al (2021) Hyperkyphosis is not dependent on bone mass and quality in the mouse model of Marfan syndrome. Bone 152:116073. https://doi.org/10.1016/j.bone.2021.116073

Article  CAS  PubMed  Google Scholar 

Delaney K, Kasprzycka P, Ciemerych MA, Zimowska M (2017) The role of TGF-β1 during skeletal muscle regeneration. Cell Biol Int 41:706–715. https://doi.org/10.1002/cbin.10725

Article  CAS  PubMed  Google Scholar 

Deleeuw V, De Clercq A, De Backer J, Sips P (2021) An overview of investigational and experimental drug treatment strategies for Marfan syndrome. J Exp Pharmacol 13:755–779. https://doi.org/10.2147/JEP.S265271

Article  PubMed  PubMed Central  Google Scholar 

Demolder A, von Kodolitsch Y, Muiño-Mosquera L, De Backer J (2020) Myocardial function, heart failure and arrhythmia in Marfan syndrome: a systematic literature review. Diagnostics 10:751. https://doi.org/10.3390/diagnostics10100751

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deprez A, El-Jalbout R, Cloutier A et al (2024) Adults born preterm have lower peripheral skeletal muscle area and strength. Sci Rep 14:21457. https://doi.org/10.1038/s41598-024-72533-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dietz HC (2007) 2006 Curt Stern award address. Marfan syndrome: from molecules to medicines. Am J Hum Genet 81:662–667.

Comments (0)

No login
gif